Log In
BCIQ
Print this Print this
 

B7-H3 ADC

  Manage Alerts
Collapse Summary General Information
Company MacroGenics Inc.
DescriptionHumanized B7-H3 (CD276) antibody-drug conjugate (ADC)
Molecular Target B7-H3 (CD276)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today